Partner Headlines - CLVS

  1. Conatus Soars On Novartis Deal, Early FDA Nod For Clovis Drug

    TalkMarkets
  2. Tesaro Ovarian Cancer Drug Gets Priority Review After FDA OKs ...

    Investors Business Daily
  3. Biotechs Fade Again In Late Day Sell-Off

    TalkMarkets
  4. Clovis Jumps After Securing FDA Approval For Ovarian Cancer Drug ...

    TalkMarkets
  5. Supernus Pharmaceuticals Breaks Out On Up Day For Biotech Stocks

    Investors Business Daily
  6. Stocks Higher As 3 Medicals Hit Buy Points; No 'Star Wars' Bump ...

    Investors Business Daily
  7. Clovis Stock Rallies After AstraZeneca-Rivaling Ovarian Cancer ...

    Investors Business Daily
  8. Ariad Pharma Could Draw M&A Fire Ahead Of Second Cancer Drug ...

    Investors Business Daily
  9. Biotech Stock Roundup: Alnylam Slumps On Revusiran Update, TESARO ...

    TalkMarkets
  10. Poor Stock Action & Trading

    TalkMarkets
  11. 6 Best Performing Drug Stocks Of September 2016

    TalkMarkets
  12. 5 Top Performing Stocks Of The Best ETF Of Q3

    TalkMarkets
  13. Gilead Slips As Former Bull Turns Bearish On Hep C Business

    TalkMarkets
  14. Benzinga's Top Initiations

    Benzinga
  15. Clovis Oncology Receives Notification of PDUFA Extension for ...

    Benzinga
  16. Benzinga's M&A Chatter for Tuesday December 1, 2015

    Benzinga
  17. Kyle Bass Builds Bull Case for Clovis Oncology

    GuruFocus
  18. Clovis Oncology Continues Lower After Consolidation

    Benzinga
  19. KaloBios, Valeant Lead Week's 5 Top Drug Stock Gainers

    IBD
  20. Morning Market Losers

    Benzinga
  21. Benzinga's Top Downgrades

    Benzinga
  22. Benzinga's Top #PreMarket Losers

    Benzinga
  23. Biotech Clovis Oncology

    IBD
  24. Mid-Afternoon Market Update: Dow Surges More Than 200 Points; ...

    Benzinga
  25. Mid-Day Market Update: Starwood Drops Following Announcement ...

    Benzinga
  26. Clovis Stumbles, AstraZeneca Leads Cancer Drug Race

    IBD
  27. What The FDA Gave Clovis Oncology In June 2013, It Has Taken ...

    Benzinga
  28. Mid-Morning Market Update: Markets Edge Higher; Marriott To Acquire ...

    Benzinga
  29. Morning Market Losers

    Benzinga
  30. Genomics Out Of 'Caveman Era,' But Still A Ways To Go

    IBD
  31. Clovis Oncology Announces U.S. and E.U. Regulatory Milestones ...

    Benzinga
  32. Clovis Oncology Announces Data Presentations at 16th World Conference ...

    Benzinga
  33. Clovis Oncology Completes US, EU Regulatory Submissions for Rociletinib ...

    Benzinga
  34. Benzinga's Top Upgrades

    Benzinga
  35. Clovis Oncology Announces Exercise in Full of Underwriters' Option ...

    Benzinga
  36. Clovis Oncology Initiates Rolling NDA Submission to the FDA for ...

    Benzinga
  37. Morning Market Losers

    Benzinga
  38. J.P. Morgan's 3 Biotechnology Picks

    GuruFocus
  39. Clovis Technology Gets Big Boost From Goldman Upgrade

    IBD
  40. Benzinga's Volume Movers

    Benzinga
  41. Morning Market Gainers

    Benzinga
  42. Benzinga's Top Upgrades

    Benzinga
  43. Benzinga's Top #PreMarket Gainers

    Benzinga
  44. Goldman Sachs Upgrades Clovis Oncology To Buy

    Benzinga
  45. Earnings Scheduled For February 25, 2015

    Benzinga
  46. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  47. Morning Market Losers

    Benzinga
  48. Clovis Oncology Enters Into Oncology Clinical Trial Collaboration ...

    Benzinga
  49. UPDATE: Stifel Reiterates On Clovis Oncology Following 3Q14 LPS

    Benzinga
  50. Morning Market Losers

    Benzinga
  51. Biotech Enters Reporting Season With Large Caps Central To Sector ...

    Benzinga
  52. US Stock Futures Flat Ahead Of Manufacturing PMI

    Benzinga
  53. Market Wrap For June 5: Markets Positive Before Friday's Employment ...

    Benzinga
  54. UPDATE: Stifel Upgrades Clovis Oncology On Favorable Risk/Reward

    Benzinga
  55. Market Wrap For June 4: Markets Slightly Higher On Light Volume, ...

    Benzinga
  56. Citi Downgrades Clovis, Rates It As High Risk

    Benzinga
  57. Benzinga's Volume Movers

    Benzinga
  58. Benzinga's Top #PreMarket Gainers

    Benzinga
  59. UPDATE: Clovis Oncology Shares Rise 12% Premarket on Positive ...

    Benzinga
  60. US Stock Futures Rise; GDP, Jobless Claims Data In Focus

    Benzinga
  61. Mid-Morning Market Update: Markets Open Higher; Francesca's Issues ...

    Benzinga
  62. Benzinga's Top Initiations

    Benzinga
  63. Mid-Day Market Update: SodaStream Drops After Weak Outlook; Beam ...

    Benzinga
  64. Mid-Morning Market Update: Markets Open Lower; Lululemon Lowers ...

    Benzinga
  65. Benzinga's Top #PreMarket Gainers

    Benzinga
  66. Clovis Oncology Announces 2014 Objectives, Financial Guidance ...

    Benzinga
  67. What The Top Stocks Of 2013 Had In Common

    IBD
  68. Clovis Oncology CO-1686 Clinical Data Accepted as Oral Presentation ...

    Benzinga
  69. Clovis Oncology Announces 2M Share Offering by Selling Stockholders ...

    Benzinga
  70. Benzinga's M&A Chatter for Tuesday November 19, 2013

    Benzinga
  71. Why Clovis Oncology Was The Short Trade Of The Day

    Benzinga
  72. UPDATE: H.C. Wainwright nitiates on Clovis Oncology On Prospects ...

    Benzinga
  73. Mid-Morning Market Update: Markets Mixed; Merck Profit Beats ...

    Benzinga
  74. Clovis Oncology's CO-1686 Demonstrates Promising Clinical Activity ...

    Benzinga
  75. Illumina Hits New High As HiSeq Yields Record Quarter

    IBD
  76. QIAGEN Announces Partnership With Clovis Oncology to Co-develop ...

    Benzinga
  77. Mid-Day Market Update: Dow Falls Over 100 Points; Active Network ...

    Benzinga
  78. Mid-Morning Market Update: Markets Open Lower; Cal-Maine Q1 Net ...

    Benzinga
  79. Mid-Day Market Update: US Stocks Turn Higher; MAKO Surgical Shares ...

    Benzinga
  80. Mid-Morning Market Update: Markets Slip; AutoZone Q4 Net Profit ...

    Benzinga
  81. Morning Market Losers

    Benzinga
  82. Benzinga's M&A Chatter for Tuesday September 24, 2013

    Benzinga
  83. Benzinga's Top Initiations

    Benzinga
  84. Benzinga's M&A Chatter for Tuesday September 17, 2013

    Benzinga
  85. UPDATE: Stifel Initiates Coverage on Clovis Oncology, Awaiting ...

    Benzinga
  86. These ETFs House The Next Biotech Takeover Targets

    Benzinga
  87. Mid-Day Market Update: Markets Slow Their Rally; JC Penney Spikes ...

    Benzinga
  88. Mid-Morning Market Update: Markets Continue Cautious Rally; Jefferies ...

    Benzinga
  89. Benzinga's Top Pre-Market Losers

    Benzinga
  90. Health Care Sector Wrap

    FoxBusiness
  91. Health Care Sector Wrap

    FoxBusiness
  92. Clovis Oncology and Array BioPharma Announce Agreement to Discover ...

    Benzinga
  93. Clovis Oncology Announces FDA Acceptance of Investigational New ...

    Benzinga
  94. End-of-Day Market Summary for January 18, 2012

    Benzinga
  95. UPDATE: JP Morgan Initiates Clovis Oncology at Overweight

    Benzinga
  96. JP Morgan Initiates Clovis Oncology at Overweight

    Benzinga
  97. JP Morgan Initiates Clovis Oncology at Overweight

    Benzinga
Trading Center